
Archives: Resources
The mHealth Connection to Advance Clinical Research
The next revolution in clinical trial execution is now taking shape in the rapid adoption of “mHealth” technologies—mobile devices ranging from smart phones to wearable health monitoring sensors. Mobile technologies have the potential to make the collection of clinical trial data more accurate, timely and convenient for study subjects.
In this white paper “The mHealth Connection to Advance Clinical Research: Emerging Role of Mobile Health and Digital Technologies to Foster Patient-centric Trials”, learn how current PPD-conducted studies assess the feasibility of wearable data collection devices in clinical trials to achieve focused endpoints and improve the patient experience.
To download the white paper, click the button below or image thumbnail.
Veterinary Brochure
PPD Laboratories’ bioanalytical lab conducts customized assay development and validations for branded and generic veterinary pharmaceuticals.
Urinary Incontinence White Paper
Read a white paper on how PPD supports successful clinical development in urinary incontinence indications.
Busy Investigators Manage Clinical Trials on the Go
PPD Laboratories is developing future lab solutions to communicate more efficiently with clients, investigators and clinical trial managers.
Project Management Dashboard Provides Visual Overview
Read an overview of the central lab project management dashboard capabilities.
Investigator Portal Reduces Errors and Improves Communication
Investigator Portal Reduces Errors and Improves Communication
Biostatistics and Medical Writing Case Study
Understand our commitment to large-scale FSP partnerships and how PPD FSP has delivered throughout a six-year partnership.
Addressing Key Challenges in the Clinical Development of Combination Immuno-oncology Therapies
This case study illustrates real-world challenges and subsequent key learnings in a global I-O combination program.
Improved risk management: benefits of predefined quality tolerance limits
PPD has established a robust and well-integrated, cross-functional process to help its sponsors
execute the QTL component of ICH E6 (R2).